These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28491796)

  • 1. LAMP2 shines a light on cardiomyopathy in an athlete.
    Martin S; Ingles J; Hunyor I; Bagnall RD; Puranik R; Semsarian C
    HeartRhythm Case Rep; 2017 Mar; 3(3):172-176. PubMed ID: 28491796
    [No Abstract]   [Full Text] [Related]  

  • 2. Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy.
    Zaki A; Zaidi A; Newman WG; Garratt CJ
    J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1051-3. PubMed ID: 23577876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Alcalai R; Arad M; Wakimoto H; Yadin D; Gorham J; Wang L; Burns E; Maron BJ; Roberts WC; Konno T; Conner DA; Perez-Atayde AR; Seidman JG; Seidman CE
    J Am Heart Assoc; 2021 Sep; 10(17):e018829. PubMed ID: 34459252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.
    Maron BJ; Roberts WC; Arad M; Haas TS; Spirito P; Wright GB; Almquist AK; Baffa JM; Saul JP; Ho CY; Seidman J; Seidman CE
    JAMA; 2009 Mar; 301(12):1253-9. PubMed ID: 19318653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
    Chen TB; Cheng KA; Gao P; Cheng ZW; Fan JB; Jiang XC; Fang Q
    Chin Med J (Engl); 2010 Apr; 123(7):848-51. PubMed ID: 20497676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden Cardiac Death.
    John RM
    Curr Treat Options Cardiovasc Med; 2004 Oct; 6(5):347-355. PubMed ID: 15324610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
    Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
    Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.
    El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic Apical Hypertrophic Cardiomyopathy in an Elite Competitive Athlete.
    Huang AL; MacNamara J; Link MS; Martinez M; Dearani JA; Cannon BC; Levine BD; Ackerman MJ
    JACC Case Rep; 2023 Jan; 6():101705. PubMed ID: 36704059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset cardiomyopathy in females with Danon disease.
    Hedberg Oldfors C; Máthé G; Thomson K; Tulinius M; Karason K; Östman-Smith I; Oldfors A
    Neuromuscul Disord; 2015 Jun; 25(6):493-501. PubMed ID: 25900304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.
    Rigopoulos AG; Daci S; Pfeiffer B; Papadopoulou K; Neugebauer A; Seggewiss H
    Clin Res Cardiol; 2016 Nov; 105(11):953-961. PubMed ID: 27270758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Identification of Mutations in
    Zhang L; Yang F; Chen M; Zhou M; Qian T; Mujtaba MO; Mohammed AH; Yin J; Cheng X; Chen J; Qin Y; Yang S
    Front Genet; 2020; 11():589838. PubMed ID: 33505424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
    Kadish A; Dyer A; Daubert JP; Quigg R; Estes NA; Anderson KP; Calkins H; Hoch D; Goldberger J; Shalaby A; Sanders WE; Schaechter A; Levine JH;
    N Engl J Med; 2004 May; 350(21):2151-8. PubMed ID: 15152060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy and sudden cardiac death due to physical exercise in Croatia in a 27-year period.
    Duraković Z; Duraković MM; Skavić J
    Coll Antropol; 2011 Dec; 35(4):1051-4. PubMed ID: 22397237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.